<bill session="113" type="h" number="1958" updated="2013-07-17T16:03:55-04:00">
  <state datetime="2013-05-14">REFERRED</state>
  <status>
    <introduced datetime="2013-05-14"/>
  </status>
  <introduced datetime="2013-05-14"/>
  <titles>
    <title as="introduced" type="short">Gray Market Drug Reform and Transparency Act of 2013</title>
    <title as="introduced" type="official">To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce.</title>
  </titles>
  <sponsor id="400090"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2013-05-14">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2013-05-17">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Business records"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
</bill>
